Literature DB >> 8293191

Cytochrome C oxidase deficiency and neuronal involvement in Menkes' kinky hair disease: immunohistochemical study.

M Sparaco1, A Hirano, M Hirano, S DiMauro, E Bonilla.   

Abstract

Antibodies against subunits II and IV of cytochrome c oxidase (COX) and against complex III of the respiratory chain were used to study the expression of these proteins in the cerebellum, spinal cord, and other regions of the central nervous system in an autoptic case of Menkes' kinky hair disease (MKHD). We found a reduced expression of COX subunits in all examined areas whereas staining for complex III appeared normal. Immunostaining was altered in morphologically well-preserved neurons, suggesting that COX deficiency may have a pathogenetic role in the neuronal degeneration of MKHD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8293191     DOI: 10.1111/j.1750-3639.1993.tb00762.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  6 in total

Review 1.  Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease.

Authors:  Stephanie Zlatic; Heather Skye Comstra; Avanti Gokhale; Michael J Petris; Victor Faundez
Journal:  Neurobiol Dis       Date:  2015-01-10       Impact factor: 5.996

2.  Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.

Authors:  Liam M Guthrie; Shivatheja Soma; Sai Yuan; Andres Silva; Mohammad Zulkifli; Thomas C Snavely; Hannah Faith Greene; Elyssa Nunez; Brogan Lynch; Courtney De Ville; Vinit Shanbhag; Franklin R Lopez; Arjun Acharya; Michael J Petris; Byung-Eun Kim; Vishal M Gohil; James C Sacchettini
Journal:  Science       Date:  2020-05-08       Impact factor: 47.728

3.  Cerebellar superoxide dismutase expression in Menkes' kinky hair disease: an immunohistochemical investigation.

Authors:  N Shibata; A Hirano; M Kobayashi; T Umahara; T Kawanami; K Asayama
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.

Authors:  Ja Hye Kim; Beom Hee Lee; Yoo-Mi Kim; Jin-Ho Choi; Gu-Hwan Kim; Chong Kun Cheon; Han-Wook Yoo
Journal:  Metab Brain Dis       Date:  2014-06-13       Impact factor: 3.584

5.  Menkes disease complicated by concurrent Koolen-de Vries syndrome (17q21.31 deletion).

Authors:  Taylor Woodfin; Christine Stoops; Joseph B Philips; Edward Lose; Fady M Mikhail; Anna Hurst
Journal:  Mol Genet Genomic Med       Date:  2019-06-28       Impact factor: 2.183

6.  Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance?

Authors:  Marco Spinazzi; Franca De Lazzari; Bruno Tavolato; Corrado Angelini; Renzo Manara; Mario Armani
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.